Kalytera Therapeutics' Unattributed - III Round

Kalytera Therapeutics raised a round of funding on March 19, 2015.

Kalytera Therapeutics (TSX VENTURE: KALY) is a clinical stage pharmaceutical company that is developing a portfolio of non-psychoactive cannabinoid and cannabinoid-modulating medicines that address la…

Articles about Kalytera Therapeutics' Unattributed - III Round: